About the Authors

Holger Thie

Contributed equally to this work with: Holger Thie, Lars Toleikis

Current address: Miltenyi Biotec GmbH, Bergisch Gladbach, Germany

Affiliation Technische Universität Braunschweig, Institut für Biochemie und Biotechnologie, Braunschweig, Germany

Lars Toleikis

Contributed equally to this work with: Holger Thie, Lars Toleikis

Current address: Merck KGaA, Darmstadt, Germany

Affiliation Technische Universität Braunschweig, Institut für Biochemie und Biotechnologie, Braunschweig, Germany

Jiandong Li

Current address: Department for Viral Hemorrhagic Fever, National Institute for Viral Diseases Control and Prevention (China CDC), Beijing, China

Affiliation Technische Universität Braunschweig, Institut für Biochemie und Biotechnologie, Braunschweig, Germany

Reinhard von Wasielewski

Current address: Bad Münder, Germany

Affiliation Hannover Medical School, Institute of Pathology, Hannover, Germany

Gunther Bastert

Current address: Mannheim, Germany

Affiliation Universitätsfrauenklinik Heidelberg, Heidelberg, Germany

Thomas Schirrmann

Affiliation Technische Universität Braunschweig, Institut für Biochemie und Biotechnologie, Braunschweig, Germany

Isabel Tourais Esteves

Affiliation LFB Biotechnologies - Research Department, Lille, France

Christian K. Behrens

Affiliation LFB Biotechnologies - Research Department, Lille, France

Bénédict Fournes

Affiliation LFB Biotechnologies - Research Department, Lille, France

Nathalie Fournier

Affiliation LFB Biotechnologies - Research Department, Lille, France

Christophe de Romeuf

Affiliation LFB Biotechnologies - Research Department, Lille, France

Michael Hust

Affiliation Technische Universität Braunschweig, Institut für Biochemie und Biotechnologie, Braunschweig, Germany

Stefan Dübel

s.duebel@tu-bs.de

Affiliation Technische Universität Braunschweig, Institut für Biochemie und Biotechnologie, Braunschweig, Germany

Competing Interests

Isabel Tourais Esteves, Christian K. Behrens, Bénédict Fournes, Nathalie Fournier and Christophe de Romeuf are employees of LFB Biotechnologies, Holger Thie is employed by Miltenyi Biotec GmbH and Lars Toleikis is employed by Merck KGaA. The authors Holger Thie, Lars Toleikis, Thomas Schirrmann, Christian K. Behrens (LFB), Christophe de Romeuf (LFB), Michael Hust and Stefan Dübel are inventors on a patent application regarding anti-MUC1 antibodies (PCT/EP2009/005218). This study was partly financed by LFB. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: HT LT RvW TS ITE CKB BF NF CdR MH SD. Performed the experiments: HT LT JL RvW ITE BF NF. Analyzed the data: HT LT JL RvW TS ITE CKB BF NF CdR MH SD. Contributed reagents/materials/analysis tools: GB. Wrote the paper: LT HT CKB MH SD.